The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

PHASE4UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Malaria Transmission
Interventions
DRUG

Artemether Lumefantrine

DRUG

Artemether Lumefantrine 6 dose regimen & single dose of Primaquine on day 0

DRUG

Artemether Lumefantrine 6 dose regimen and single dose Primaquine on day 2

Trial Locations (1)

Unknown

RECRUITING

Bagamoyo Research and Training Centre, Bagamoyo

All Listed Sponsors
collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Ifakara Health Institute

OTHER

lead

Kilimanjaro Clinical Research Institute

OTHER

NCT01906788 - The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy | Biotech Hunter | Biotech Hunter